Advertisement

Preparation of Calpastatin Samples for Western Blotting

  • Masatoshi Maki
  • Kiyotaka Hitomi
Part of the Methods in Molecular Biology™ book series (MIMB, volume 144)

Abstract

Determination of calpastatin levels in cells or tissues by Western blotting using antibodies, or by assay of calpain inhibitory activities in vitro, may be required to assess the role and the level of calpastatin, with respect to the levels of other components of the calpain system, in certain cell biological phenomena. Although calpastatin is resistant to heat or denaturants, it is extremely labile to cellular proteases (1). The wide range and heterogeneity of the apparent molecular masses of calpastatins (17–170 kDa), as revealed by Western blotting of extracts of different tissues and cells, is due both to degradation of the proteins during preparation, and also to alternative splicing and posttranslational modifications (2, 3, 4). In addition to these factors, estimation of molecular weight is unusually difficult because calpastatins migrate abnormally slowly in sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), so that their molecular masses are overestimated by 40–60% (5). Full-length calpastatins (made up of domains L and 1–4) from most tissues of human, rabbit, pig, and others, migrate as 110–120 kDa proteins in SDS-PAGE. However calpastatin from bovine heart migrates as a protein of 140–170 kDa (1), probably because this calpastatin has an amino-terminal amino acid sequence (XL region) upstream of the previously assigned translation initiation codon (6). In contrast, erythrocyte calpastatins lack amino-terminal domains and migrate as 70-kDa proteins (7,8).

Keywords

Wash Buffer Tris Base Apparent Molecular Mass Bovine Heart Cellular Protease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Parkes C. (1986) Calpastatins, in Proteinase Inhibitors (Barrett A. J., and Salvesen G. eds.), Elsevier, Amsterdam, pp. 571–587.Google Scholar
  2. 2.
    Maki M., Ma H., Takano E., Adachi Y., Lee W. J., Hatanaka M., and Murachi T. (1991) Calpastatins: Biochemical and molecular biological studies. Biomed. Biochim. Acta 50, 509–516.PubMedGoogle Scholar
  3. 3.
    Takano E., Nosaka T., Lee W. J., Nakamura K., Takahashi T., Funaki M., Okada H., Hatanaka M., and Maki M. (1993) Molecular diversity of calpastatin in human erythroid cells. Arch. Biochem. Biophys. 303, 349–354.PubMedCrossRefGoogle Scholar
  4. 4.
    Lee W. J., Ma H., Takano E., Yang H. Q., Hatanaka M., and Maki M. (1992) Molecular diversity in amino-terminal domains of human calpastatin by exon skipping. J. Biol. Chem. 267, 8437–8442.PubMedGoogle Scholar
  5. 5.
    Takano E., Maki M., Mori H., Hatanaka M., Marti T., Titani K., Kannagi R., Ooi T. and Murachi T. (1988) Pig heart calpastatin: Identification of repetitive domain structures and anomalous behavior in polyacrylamide gel electrophoresis. Biochemistry 27, 1964–1972.PubMedCrossRefGoogle Scholar
  6. 6.
    Cong M., Thompson V. F., Goll D. E., and Antin P. B. (1998) The bovine calpastatin gene promoter and a new N-terminal region of the protein are targets for cAMP-dependent protein kinase activity. J. Biol. Chem. 273, 660–666.PubMedCrossRefGoogle Scholar
  7. 7.
    Takano E., Kitahara A., Sasaki T., Kannagi R., and Murachi T. (1986) Two different molecular species of pig calpastatin: Structural and functional relationship between 107 kDa and 68 kDa molecules. Biochem. J., 235, 97–102.PubMedGoogle Scholar
  8. 8.
    Imajoh S., Kawasaki H., Emori Y., and Suzuki K. (1987) Calcium-activated neutral protease inhibitor from rabbit erythrocyes lacks the N-terminal region of the liver inhibitor but retains three inhibitory units. Biochem. Biophys. Res. Commun. 146, 630–837.PubMedCrossRefGoogle Scholar
  9. 9.
    Kikuchi H. and Imajoh-Ohmi S. (1995) Antibodies specific for proteolyzed forms of protein kinase Cα. Biochim. Biophys. Acta 1269, 253–259.PubMedCrossRefGoogle Scholar
  10. 10.
    Yu D., Imajoh-Ohmi S., Akagawa K., and Kanegasaki S. (1996) Suppression of superoxide-generating ability during differentiation of monocytes to dendritic cells. J. Biochem. 119, 23–28.PubMedGoogle Scholar
  11. 11.
    Wang K. K., Posner A., and Hajimohammadreza I. (1996) Total protein extraction from cultured cells for use in electrophoresis and Western blotting. Biotechniques 20, 662–668.PubMedGoogle Scholar
  12. 12.
    Schwarz-Benmeir N., Glaser T., Barnoy S., and Kosower N. S. (1994) Calpastatin in erythrocytes of young and old individuals. Biochem. J. 304, 365–370.PubMedGoogle Scholar
  13. 13.
    Hitomi K., Yokoyama A., and Maki M. (1997) Expression of biologically active human calpastatin in baculovirus-infected insect cells and in Escherichia coli. Biosci. Biotech. Biochem. 62, 136–141.CrossRefGoogle Scholar

Copyright information

© Humana Press Inc. 2000

Authors and Affiliations

  • Masatoshi Maki
    • 1
  • Kiyotaka Hitomi
    • 1
  1. 1.Laboratory of Molecular and Cellular Regulation, Department of Applied Molecular Biosciences, Graduate School of Bioagricultural SciencesNagoya UniversityNagoyaJapan

Personalised recommendations